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Background: While safer than their viral counterparts, conventional non-viral gene delivery DNA vectors offer a
limited safety profile. They often result in the delivery of unwanted prokaryotic sequences, antibiotic resistance
genes, and the bacterial origins of replication to the target, which may lead to the stimulation of unwanted
immunological responses due to their chimeric DNA composition. Such vectors may also impart the potential for
chromosomal integration, thus potentiating oncogenesis. We sought to engineer an in vivo system for the quick
and simple production of safer DNA vector alternatives that were devoid of non-transgene bacterial sequences and
would lethally disrupt the host chromosome in the event of an unwanted vector integration event.
Results: We constructed a parent eukaryotic expression vector possessing a specialized manufactured multi-target
site called “Super Sequence”, and engineered E. coli cells (R-cell) that conditionally produce phage-derived
recombinase Tel (PY54), TelN (N15), or Cre (P1). Passage of the parent plasmid vector through R-cells under
optimized conditions, resulted in rapid, efficient, and one step in vivo generation of mini lcc—linear covalently
closed (Tel/TelN-cell), or mini ccc—circular covalently closed (Cre-cell), DNA constructs, separated from the
backbone plasmid DNA. Site-specific integration of lcc plasmids into the host chromosome resulted in
chromosomal disruption and 105 fold lower viability than that seen with the ccc counterpart.
Conclusion: We offer a high efficiency mini DNA vector production system that confers simple, rapid and scalable
in vivo production of mini lcc DNA vectors that possess all the benefits of “minicircle” DNA vectors and virtually
eliminate the potential for undesirable vector integration events.
Keywords: Mini DNA vectors, Linear covalently closed plasmid vector, DNA vector integration, Non-viral gene
delivery, “minicircles”, Bacteriophage PY54 Tel/pal recombination system, Bacteriophage N15 TelN/telRL
recombination system, Bacteriophage P1 Cre/loxP recombination system, Bacterial engineeringBackground
The utility of any gene therapy strategy is defined by its
balance between safety and effectiveness. While virus-
derived vectors offer exceptional potential to target and
deliver DNA cargo with high efficiency into the target
cell, viral strategies often suffer in their safety profiling.
Recent viral gene therapy-related patient mortalities in
clinical trials highlight some of the safety issues attribu-
ted to the use of viral gene transfer systems that include,
but are not limited to unwanted immune responses to* Correspondence: slavcev@uwaterloo.ca
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distribution, and reproduction in any mediumviral capsid proteins, regeneration of virulent viruses,
and insertional mutagenesis [1]. In contrast, non-viral
strategies based on naked, lipoplexed or polyplexed plas-
mid DNA (pDNA) vectors generally offer safer gene
therapy, vaccine design, and drug delivery approaches.
Plasmid DNA vectors are relatively easy to generate and
store and offer tremendous design capacity. Several
major barriers need to be considered in order to develop
non-viral gene delivery systems as a therapeutic product
to be safely administered in vivo. A successful transgene
delivery system depends on the entrance of the DNA
vector into the mammalian host nucleus and expression
of the encoded transgene(s). While simple in theory, sev-
eral cellular barriers must be overcome in practice.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tors must be bio- and immuno-compatible and avoid
degradation by serum nucleases and immune detection
by phagocytes. Plasma nucleases digest the unprotected
DNA within just a few minutes, so DNA vectors need
to rapidly cross the plasma membrane of target cells.
This is further complicated by the fact that the plasma
membrane is composed of dense lipoprotein barriers that
intrinsically inhibit efficient DNA translocation. Stra-
tegies to overcome this barrier include complexing DNA
vectors with synthetic nanoparticles to form a structure
similar to the plasma membrane [2] or receptor-
mediated endocytosis; i.e. targeted liposomes [3]. How-
ever, while non-viral gene delivery techniques work
toward efficiency of DNA delivery, they generally prove
poor in the delivery of pDNA vectors to the nuclear com-
partment. Many techniques are currently being investi-
gated to enhance levels of non-viral gene transfer by
targeting vectors to the nucleus. These techniques in-
clude modification of plasmids with DNA nuclear target-
ing sequences (DTS), covalent linkage of nuclear
localization signals (NLS) to the plasmid DNA con-
structs, and attachment of import receptors such as kar-
yopherins, to vectors that promote uptake through the
nuclear membrane pore complex (NPC) [2,4,5]. Modifi-
cation of DNA with NLS-conjugates seems to result in
highly efficient expression of linear, but not circular
DNA, in combination with liposomal delivery vectors [6].
This difference may be attributed to charge per unit ratio
of linear versus supercoiled circular DNA and provides
yet another intriguing opportunity for lcc vectors [7].
In addition to the aforementioned challenges, conven-
tional non-viral gene delivery approaches may lead to
unwanted immunological responses and oncogenesis,
imparted by the presence of bacterial genetic elements
in plasmid DNA constructs. These include prokaryotic
origins of replication, antibiotic resistance genes, as well
as high-frequency immunostimulatory CpG motifs that
activate Toll-like receptors in mammalian hosts [8]. In
order to improve the immuno-compatibily and durabil-
ity of plasmid DNA vectors, a new generation of DNA
vectors have been constructed that exploit the bacterio-
phage λ integrase (Int)-attP or P1-derived Cre-loxP site-
specific recombination systems to generate mini ccc
DNA vectors [9]. These “minicircles” provide safer
minimized transgene vectors by removing unwanted
prokaryotic elements, thus enhancing bio- and immuno-
compatibility in the mammalian host [10]. The smaller
size compared to the parental plasmid backbone also
confers improved extracellular and intracellular bioavail-
ability leading to efficient gene delivery and hence,
improved gene expression [11].
A second group of modified vectors offering great
promise are linear covalently closed (lcc) plasmid DNAvectors. Aside from the obvious topological differences,
lcc double-stranded DNA molecules are torsion-free as
they are not subject to gyrase-directed negative super-
coiling, and as such possess the properties of linear
DNA [12]. However, lcc DNA is not subject to ExoV
exonuclease activity in prokaryotes due to covalent link-
age of linear ends, preventing degradation of the lcc
pDNA vector. Lcc DNA vectors have been constructed
by various in vitro strategies including the capping of
PCR products, and the “minimalistic immunogenic
defined gene expression (MIDGE)” vectors. MIDGE is
generated by the digestion of both prokaryotic and
eukaryotic backbones after isolation of plasmid from
bacterial cells, followed by ligation of the therapeutic ex-
pression cassette into hairpin sequences for end-refilling
[13]. This technology has shown promising results in
various applications including the development of a
Leishmania DNA vaccine [14] and a colon carcinoma
treatment [15]. MIDGE vectors have also demonstrated
up to 17 fold improved transgene expression profile
in vivo in some tissues, compared to conventional plas-
mid DNA vectors [16]. Thus, lcc DNA vectors may in
fact outperform their circular counterparts with respect
to expression efficiency and bioavailability. However,
large-scale production of lcc DNA vectors via existing
multistep in vitro processes requires considerable time
and financial cost.
E. coli phage N15 was the first discovered phage to
exist in its lysogenic (prophage) state as a linear cova-
lently closed (lcc) plasmid [17] that is actively partitioned
to daughter cells [18]. The lcc conformation is conferred
by the cleaving-joining activity of the protelomerase
protein (Prokaryotic Telomerase), TelN (~72 kDa), act-
ing upon the 56 bp telRL target sequence that is en-
tirely sufficient to confer TelN-mediated processing and
linearization both in vivo and in vitro [19,20]. Similarly,
phage PY54, isolated from Yersinia enterocolitica, main-
tains its prophage as a linear, circularly permuted, and
covalently closed plasmid with telomere hairpin ends
and a genome size of 46 kb. The paralogous minimal
protelomerase target site of PY54 is a 42 bp perfect
palindrome that unlike N15, only partially functions
in vivo in the absence of adjacent sequences [21]. The
paralogue of the N15 TelN protelomerase, Tel, encodes a
77 kDa protein with observably identical function, able
to process recombinant plasmids containing the pal,
42 bp palindromic target site [21]. The tel gene possesses
60% sequence identity to telN and the active recombi-
nases are similar in size (~77 kDa). In addition, there is a
partial homology between the 42 bp PY54 pal site and
the 56 bp N15 telRL site, where the ten central palin-
dromic nucleotides (5'-TACGCGCGTA-3') are identical
[21]. Despite obvious similarities between the two phages
they are evolutionary quite distant, where N15 is more
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shown to process circular and supercoiled plasmid DNA
containing the identified target site, telRL, to produce lin-
ear double-stranded DNA with covalently closed ends.
The lcc and mini lcc DNA vectors produced in vitro by
recombinant TelN have been successfully applied in gene
delivery experiments, and showed higher and more dur-
able expression of the gene of interest in targeted human
cells [20,21]. In contrast, to the best of our knowledge,
there are no reported applications of the Tel-pal system.
Furthermore, current TelN-telRL applications are based
on recombinant TelN production for in vitro lcc DNA
vector generation [22]. In this study, we report for the
first time the development and characterization of an
optimized in vivo mini lcc DNA production platform,
exploiting the Tel-pal and TelN-telRL recombination
systems. This one-step production system combines the
biocompatibility benefits of “minicircles” with the trans-
fection efficiency and safety profile of “MIDGE”.Figure 1 R-cell construction and temperature-regulated expression o
expression of recombinases, Tel and TelN. The cI857-R cassette was inserted
repressed (25-30°C) conditions, the λ temperature-sensitive CI857 repressor
but upon shifting to 40-42°C, the repressor is denatured, falling off the ope
pL/pR promoter. B. Controllable Tel and TelN expression from R-cells. Expre
and induced (42°C) conditions from total R-cell extract. Lane 1: Weight marResults
R-cells exhibit temperature-regulated recombinase
expression
Recombinant E. coli cells (R-cells) were constructed that
place tel or telN recombinase genes under control of the
bacteriophage λ strong promoter, pL, that is regulated
by the temperature-sensitive λ repressor, CI[Ts]857
(Figure 1A). We also similarly constructed cre-expressing
cells to serve as a positive control, where in vivo Cre-loxP
activity is well documented [23,24]. We examined total
cellular protein in tel and telN R-cells under repressed
(30°C) and fully induced (42°C) conditions (Figure 1B).
As expected, both R-cells demonstrated minimal recom-
binase protein levels, identified at 72 kDa for both TelN
and Tel at 30°C, where CI[Ts] actively binds the oL op-
erator and represses transcription of the downstream re-
combinase gene. Upon shifting cells to 42°C, where
repressor activity is completely abrogated and occlusion
of pR and pL promoter activity is relieved, prominentf Tel and TelN. A. R-cell construction and temperature-regulated
into the lacZ gene of E. coli by homologous recombination. Under
binds to λ operators to inhibit transcription of the recombinase gene,
rators and induces expression of the recombinase from the strong λ
ssion of the recombinase proteins Tel and TelN under repressed (30°C)
ker; Lane 2: Recombinase.
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confirm that the constructed Tel+ and Tel-N+ cells are
temperature inducible for recombinase production.
In combination with the R-cell system, we next con-
structed a eukaryotic egfp-expression plasmid DNA vec-
tor that carries two specialized 343 bp sequences placed
upstream of the SV40 promoter and downstream of
the polyadenylation signal of the minimal egfp expression
cassette (pNN9; Figure 2A). This construct, termed
“Super Sequence” (SS) carries a modified pal target se-
quence of Tel, with integrated telRL (TelN), loxP (Cre)
and FRT (Flp) sequences in non-binding regions of pal
sequence, and SV40 enhancer sequences that flank
pal on either side to enhance nuclear translocation
(Figure 2B). The rationale behind the multi-target se-
quence composition of SS was to allow the same parent
plasmid vector to be passed through different R-cells to
generate either mini lcc or mini ccc conformation of the
minimal expression cassette. We employed the pNN9
(5.6 kb) plasmid to confirm that controlled productionFigure 2 Parent plasmid pNN9 and "Super Sequence" multi-target sit
primary genetic elements, including the designed and integrated Super Se
includes relative locations of SV40 enhancer sequences as well as the telRL
142 bp pal target site (Tel).of recombinase from R-cells was associated with control-
lable recombinase enzymatic activity, by examining
the ability of R-cells to convert plasmids carrying
the SS sites to the appropriate mini lcc (Tel or TelN)
or mini ccc (Cre) conformation. The SS+-derivative
(pNN9; Table 1) was passaged through Tel/TelN+ or
Cre+ R-cells at optimized conditions and assessed for-
mation of mini lcc or mini ccc DNA vectors during
the one-step in vivo processing and amplification
protocol (Figure 3A). By flanking the gene of interest
(GOI) expression cassette with two SS sites, we
expected to excise the GOI (2.4 kb) for easy separation
from the remaining prokaryotic backbone (3.2 kb) par-
ental DNA, including the origin of replication and ApR
marker at temperatures inducing recombinase expres-
sion (Figure 3B). Recombinase activity on pNN9 was
evident when the plasmid was processed at 42°C where
R-cell recombinase expression was “on”. No SS+ plas-
mid processing was evident at 30°C when expression
was “off”, or with the SS— control plasmids under alle. A. Map of the parent pNN9 construct. The map denotes location of
quence (SS). B. Map of the Super Sequence construct. The map
, loxP and FRT sequences integrated into non-binding regions of the
Table 1 Bacteria, Phage and Plasmids
Strain Genotype or description Source
Bacteria
BW23474 F-, Δ(argF-lac)169, ΔuidA4::pir-116, recA1, rpoS396(Am), endA9(del-ins)::FRT, rph-1,
hsdR514, rob-1, creC510
E. coli Genetic Stock Center (CGSC) # 7838 [39]
DH5α F-, Δ(argF-lac)169, ϕ80dlacZ58(M15), ΔphoA8, glnV44(AS), λ-, deoR481, rfbC1, gyrA96
(NalR), recA1, endA1, thi-1, hsdR17
CGSC # 12384
DH5α λpir F-, Δ(argF-lac)169,endA1, pir+, recA1 Gift from Dr. T. Charles; [40]
JM109 F', Δ(gpt-lac)0, glnV44(AS), λ-, rfbC1, gyrA96(NalR), recA1, endA1, spoT1?, thi-1, hsdR17,
pWM5, F128-x
New England Biolabs
W3101 F-, λ-, galT22, IN(rrnD-rrnE)1, rph-1 CGSC # 4467;
W3110 F-, λ-, IN(rrnD-rrnE)1, rph-1 CGSC # 4474;[41]
W3110-Cre
(W1NN)
F-, λ-, IN(rrnD-rrnE)1, rph-1 lacZ::cat-cI857-cre (CmR) This study
W3110-TelN
(W2NN)
F-, λ-, IN(rrnD-rrnE)1, rph-1 lacZ::cat-cI857-telN (CmR) This study
W3110-Tel
(W3NN)
F-, λ-, IN(rrnD-rrnE)1, rph-1 lacZ::cat-cI857-tel (CmR) This study
Phages
N15 Wild type (wt) (telN+, tos+) Gift from Dr. S. Hertwig; [21]
P1 wt (cre+, loxP+) Gift from Dr. B. Funnell; [42]
PY54 wt (tel+, pal+) Gift from Dr. S. Hertwig; [21]
Plasmids
pAH120 attP λ integration plasmid (KnR) NBRP [25]
pAH123 cI857-pL-int Φ80 (ApR) NBRP [25]
pAH153 attP Φ80 integration plasmid (KnR) NBRP [25]
pBRINT lacZ::cat-MCS::lacZ (CmR) NBRP; [37]
pGL2 SV40P-Luc-PolyA-SV40 intron Promega
pInt(ts) cI857-pL-int λ (ApR) NBRP [25]
pNN1 cI857-pR-pL-cre-tL (ApR) This study
pNN2 cI857-pR-pL-tel-tL (ApR) This study
pNN3 cI857-pR-pL-telN-tL (ApR) This study
pNN4 lacZ::cat- cI857-pR-pL-cre-tL::lacZ (CmR) This study
pNN5 lacZ::cat- cI857-pR-pL-tel-tL::lacZ (CmR) This study
pNN6 lacZ::cat- cI857-pR-pL-telN-tL::lacZ (CmR) This study
pNN7 pGL2-egfp switched for luc This study
pNN8 pNN7 + SS (upstream of SV40 promoter) This study
pNN9 pNN8-SS (2SS) (second SS downstream of SV40 polyA sequence) This study
pNN10 pAH120 (SS+) This study
pNN11 pAH153 (SS+) This study
pPL451 cI857-pR-pL-MCS-tL (ApR) Accession # AB248919 National Bioresource
Project (NBRP); [43]
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linearization conditions for pNN9 were conducted in
both Tel+ and TelN+ cells and pNN9 processed products
were extracted and analyzed. During the optimization
process, different thermal conditions were tested to de-
termine the ideal induction stage during R-cells growth
and the induction duration that generates maximum re-
combinase production and plasmid processing. We
found that shifting the temperature at late logarithmicphase to 42°C for 30 min to induce R-cells conferred op-
timal recombinase expression and plasmid processing.
In all cases, extracted mini lcc DNA vectors behaved
with equivalent stability in storage and manipulation to
their ccc counterparts or parental plasmid DNA (data
not shown). Linearization of pNN9 and extraction of the
mini lcc vector, was also much more efficient in Tel+, as
compared to the TelN+ counterpart (Figure 3C). These
findings indicate that Tel is active upon pal+ constructs
Figure 3 Conditional processing of the parent plasmid DNA vectors. A. R-cell conditional processing of the parent pNN9 plasmid into mini
vectors. Under induced conditions, R-cells lead to the production of mini lcc (TelN- or Tel-cell) and mini ccc (Cre-cell) DNA vectors by
recombinase activity on its target site encoded within the 2 Super Sequence sites on pNN9. Processing of the parent plasmid DNA results in
production of two species—the mini DNA vector and the mini plasmid backbone. B. Processing of the parent plasmid construct into mini lcc
and mini ccc vectors. Efficiency of processing of the pNN9 plasmid into mini lcc DNAs (Tel) and “minicircles” (Cre) after plasmid extraction from
R-cells under induced (42°C) conditions. Schematics adjacent to each bands show the DNA constructs and expected conformation. C. In vivo
Tel-pal recombination efficiency versus TelN-telRL. Efficiency of processing of the pNN9 plasmid into mini lcc DNA vectors in Tel+ versus TelN+ R-cells.
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through the addition of loxP, FRT, and telRL minimal
target sequences into non-binding regions of the full
142 bp pal target site does not abrogate Tel-pal
functionality.Integration of lcc DNA vector into the chromosome
results in loss of cell viability
We asked whether a single crossover recombination
event integrating a linear pDNA vector with covalently
closed ends into a host cell chromosome would disrupt
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the outcome of linearizing the E. coli chromosome by
lcc DNA integration, we employed an in vivo approach
by exploiting λ and Φ80 Int-att site-specific recombin-
ation systems [25] in a Rec+ background. To target the
chromosome, an integrating plasmid vector that carries
the λ attP target site of the λ integrase and an R6K ori-
gin was used as it is only capable of replication in the
presence of π protein (encoded by pir gene), which is
absent from all R-cells. As such, the plasmid is either
integrated or rapidly lost from the growing R-cell popu-
lation. An SS was incorporated into the integrating
pDNA vector to change plasmid conformation from ccc
to lcc in the presence of TelN or Tel in R-cells. Using
this system we sought to assess integration efficiency
following transformation of parent, Tel+ or TelN+ R-
cells by SS— and SS+ integrating plasmid vectors under
conditions induced or repressed for recombinase ex-
pression in R-cells. A ccc λ or Φ80 attP+ SS+ plasmid
that is taken up by the cell expressing λ or Φ80 int, re-
spectively, and producing Tel or TelN, should be altered
from ccc to lcc conformation. Upon Int-mediated att-
specific chromosomal integration, the recombination of
lcc should disrupt the chromosome. And, as unintegrated
plasmids are incapable of replication, they would be
rapidly lost from the cell population.
The integration frequency (IF) of λ attP SS+ integrat-
ing plasmids into induced Tel+R-cells was more than
105-fold lower than that seen for the SS— counterpart or
the SS+ integrating plasmids in parent W3110 cells
(Table 2). TelN+ R-cells did not demonstrate nearly as
strong an effect, whereby IF compared to the wild type
cells was 50-fold lower, and only 25-fold lower versus in-
tegration of the SS— derivative. We further studied up to
20 survivor isolates from both TelN+ and Tel+ cells byFigure 4 Schematic representations of linear and circular vector integ
event with the host chromosome is rare due to the removal of all element
flanking Super Sequence sites. A. Lcc plasmid DNA vector integration even
whereby the chromosome cannot be replicated or segregated and the int
centromere from telomere. B. A “minicircle” vector can integrate into a non
chromosome, whereby the cell is able to continue dividing with the insertPCR for evidence of chromosomal linearization, and
found that 100% of tested survivors possessed intact
(unlinearized) plasmid. These findings are likely due to
the a higher efficiency of Tel-pal system in formation of
a lcc product as compared to TelN acting on the min-
imal telRL target site encoded within the SS. Although
we attempted to repeat this experiment using a con-
structed Φ80 attP SS+ integrating pDNA vector by the
R-cells expressing Φ80 int, we found that integration
frequencies were lower across all tested cells.
We next sought to investigate chromosomal linear-
ization by constructing SS+ or SS— integrants using the
same λ and Φ80 Int-attP plasmid integration system.
Unlike the previous experiment, this time, rather than
assessing the number of integrants formed in the pres-
ence of the linearizing recombinase, we first stably
integrated the plasmid into the chromosome before
inducing recombinase expression. Cells carrying the
integrated SS+ or SS— vector were maintained under
repressed tel and telN conditions (30°C) and several
isolates were assessed for integration of single versus
multiple copies of plasmid by PCR. In all cases, single
integration events represented the majority of recombi-
nants for both SS+ and SS— λ or Φ80 attP integrating
plasmids (56.5-100%). Multiple copy integrants were
not studied further and discarded.
To determine the fate of cells upon linearizing/disrupt-
ing the E. coli chromosome, we incubated λ site-specific
SS— and SS+ integrants under conditions that provide
no to very low, or fully derepressed expression of the re-
combinase at 30°C and 42°C, respectively, and then mea-
sured cell viability (Table 3). Under repressed conditions
(30°C), all recombinant cells retained near full viability
regardless of the presence or absence of the SS inte-
grated in the chromosome. However, upon shiftingration events. A mini vector that undergoes a single recombination
s except the cistron containing the GOI expression cassette and the
t would result in chromosomal ”break” at the site of integration,
egrated mammalian cell cannot divide due to separation of
-essential region of the host chromosome without “breaking” the
ion.
Table 2 Linear covalently closed (lcc) plasmid confers
reduced integration frequency






Tel + 1.03 X 10-5
1 R-cells are all W3110 derivatives expressing recombinase gene at 42°C the
recombinase gene is fully induced . R-cells carry the λ int expression plasmid
pAH153.
2 pAH120 plasmid carrying λ attP.
3 Mean of minimum 3 trials. IF is expressed as fraction of integration
frequency of parent strain, W3110.
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TelN, recombinants that carried SS+ showed dramatic-
ally reduced viability. And, in both systems, Tel-cells
resulted in approximately 5-fold greater killing than that
seen in TelN-cells. Interestingly, the killing effect of SS+
plasmid in Φ80 attB site was about 10-fold lower than
was observed when integrated into λ attB site. This find-
ing suggests that positioning of the attB site may influ-
ence the viability of cells with a linear chromosome.
Visualization of Cells upon induction
Wild type and Tel-cells carrying chromosomally inserted
SS+ or SS— integrating plasmid vectors were gram
stained and visualized under repressed (30°C) versus
induced (42°C) conditions for tel recombinase expres-
sion to investigate cell morphology as a result of
chromosomal disruption (Figure 5). At 42°C, only SS+
Tel+ integrants demonstrated a highly contracted and
irregular morphology compared to SS— cells, or SS+
cells grown at 30°C, repressed for tel expression. WeTable 3 Recombinase-mediated linearization of the






Cell viability following induction 3
30oC 42oC
TelN — λ 0.8 0.6
TelN + λ 1.0 5.7 X 10-4
TelN — Φ80 0.8 0.4
TelN + Φ80 1.0 5 X 10-3
Tel — λ 1.0 1.0
Tel + λ 1.0 1.3 X 10-4
Tel — Φ80 1.0 0.8
Tel + Φ80 1.0 1.1 X 10-3
1 R-cells are all W3110 derivatives cured of pAH153 plasmid during
construction stage and confirmed for single integration event by PCR.
2 pAH120 plasmid carrying λ attP grown and prepared under minimal
inducing conditions (30°C).
3 Average of minimum 3 trials. Viability is expressed as a fraction of colonies
counted under non-induced (25°C) conditions.screened 10 Tel+/SS+ colonies that grew at 42°C, for
linearization by PCR and found that all of the colonies
showed an unlinearized SS+ plasmid insert (data not
shown). Surviving colonies were however, very small
compared to their SS— counterpart or the wild type
parent, and retained this morphology whether grown
under inducing or repressed conditions. We averaged
the length of 400 randomly selected cells. We noted
that the SS— controls were similar at both 30o and 42°C
with a normal average length for log phase E. coli in
rich medium, measuring 3.9 ± 0.4 and 3.9 ± 0.6 μm re-
spectively. In contrast, cells, possessing the chromoso-
mally integrated SS site, were much smaller at 42°C,
where tel expression was fully induced, and averaging
only 1.2 ± 0.2 μm in length. In contrast, a small propor-
tion of these cells (1.5%) were filamentous. This may be
attributed to replication delay or inhibition in these
cells. Under the conditions where we would expect
chromosomal disruption, we also observed a great deal
of cellular debris. At 30°C, where tel expression was
repressed, cells were considerably larger at 3.0 ± 0.8 μm
but there was a much greater variability in size between
cells ranging from 1.2 to 4 μm. This variability could be
the consequence of leaky expression of tel due to in-
complete repression of the CI[Ts]857 repressor at 30°C.
Discussion
To date, mini DNA vector production has been limited
to in vitro strategies, adding expense and complexity to
the developmental process, particularly in scalability.
The mini DNA vector production system, described
here, is an in vivo platform to generate high quality bac-
terial sequence-free mini DNA vectors in both lcc and
ccc topology. Modified mini vectors can be purified dir-
ectly from our engineered E. coli cells (R-cells) using
standard plasmid isolation methods, and without the
need for digestion, ligation, and gel purification. To gen-
erate R-cells, we flanked the cI[Ts]857-protelomerase ex-
pression cassettes by homology to lacZ gene and
recombined the cassette into recA+ W3110 E. coli cells
screening for Lac- colonies. R-cells were designed and
optimized to chromosomally encode specific recombi-
nases under control of a strong λ pL promoter. However,
since strong promoters impart metabolic burden on the
host cell, where protein production may occur at the ex-
pense of cell growth [26], we employed a simple
thermally-regulated promoter system that circumvents
any potential toxicity, metabolic stress or recombinase
interference that might arise from the use of chemical-
mediated induction strategies. As such we were able to
optimize the production of mini DNA vectors through
simple control over manufacture temperature using the
λ CI[Ts]857 oL-pL expression system [27]. Various mod-
ifications to our parent vector construct by simple
Figure 5 Effect of Tel-mediated chromosomal disruption on cell morphology. Tel-mediated disruption of the host chromosome results in a
contracted cellular morphology. Tel+ R-Cells possessing an integrated plasmid that was SS+ (pal+) or SS— (pal—) were grown in LB media at 30°C
(no Tel production) to early log phase A600 = 0.2 , then were divided in two tubes and grown separately at 30°C or 42°C to reach to late log
phase A600 = 0.8. Bacterial smears were then prepared on the slide and heat fixed and gram stained. Pictures of bacteria were taken at 1000X
magnification. A. SS— integrants at 30°C where tel expression is repressed; B. SS— integrants at 42°C where tel is induced but the pal target site is
absent; C. SS+ integrants at 30°C where pal target site is present but tel expression is repressed; D. SS+ integrants at 30°C where tel is induced and
present to act on the chromosomally integrated pal target site.
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the insertion of the unique multi-target sequence (Super
Sequence) described for the first time here. The Super
Sequence inserts the cleave-joining multi-target site for
TelN, Cre, and Flp enzymes within the non-coding
regions of the 142 bp minimal sequence of pal site
required for in vivo processing by Tel [21]. The retained
activity of Tel in processing this site indicates that
the replacement of non-coding regions within the
pal sequence of PY54 does not compromise cleave-
joining activity of the Tel-pal system.
Mini linear covalently closed (lcc) DNA vectors, de-
void of parental prokaryotic genetic elements were suc-
cessfully generated in vivo exploiting the bacteriophage
PY54-derived protelomerase recombination system. The
mini vector produced via this system is a stable linear
DNA expression cassette with covalently closed ends.
Application of pDNA vectors in naked, lipoplexed, or
polyplexed form for gene transfer conventionally
employs plasmid vectors designed either to administer
genes coding for therapeutic proteins, antigens, or anti-
bodies into a given organism; or introduce a correct
gene into a host cell to replace the mal- or non-
functional allele [28]. Derived from conventional plasmid
DNA vectors, bacterial sequence-free mini DNAderivatives provide superior alternatives to traditional
plasmid vectors, with some advancing in clinical trials
[29]. Conventional plasmid vectors carry a bacterial
backbone in addition to the cistron expressing the gene
of interest (GOI) in addition to necessary regulatory ele-
ments such as the promoter, enhancer, intron, and polyA
terminal sequence. While necessary for amplification
and maintenance in the prokaryotic host, the plasmid
vector backbone carries prokaryotic genetic elements,
including antibiotic resistance gene(s) and an origin of
replication. It was previously shown that antibiotic re-
sistance genes are undesirable for administration to
human body due to potential adverse effects and events
such as their horizontal gene transfer imparting resist-
ance to naturally occurring mammalian host flora; and
their compromising effect on GOI expression [30]. CpG
motifs, 20 times more common in prokaryotic DNA, in-
duce polygonal B-cell activation and activate Toll-like
receptors that in addition to generating potentially un-
wanted immunostimulatory responses, may also reduce
or abrogate transgene expression [30,31].
Bacterial sequence-free mini DNA vectors provide bet-
ter bioavailability compared to conventional plasmid
DNA vectors due to their smaller size and higher
immuno-compatibility due to reduced or eliminated
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higher transfection efficiency and higher copy numbers
of the vector per unit mass, resulting in lower toxicity
due to the need for less transfection reagents. Smaller
pDNA vectors also better resist shear forces associated
with the in vivo administration and delivery to the target
site [32], important improvements to safety and effi-
ciency of transgene delivery in treatment of human
disease [33].
Conventional plasmid vectors are extra-chromosomal,
circular, covalently closed, double-stranded DNA mole-
cules that often possess elements or sequences such as
viral promoters or cloned coding sequences that could
subject them to unwanted recombination events [34]. A
major safety concern associated with gene delivery,
whether by viral or non-viral carriers, is the potential for
integration of plasmid DNA into the host chromosome.
Integration events that activate proto-oncogenes and/or
deactivate tumor suppressor genes may result in onco-
genesis or silencing of adjacent genes [35]. We showed
here that the frequency of viable integrants of lcc pDNA
vector into the circular prokaryotic E. coli genome is
reduced at least five orders of magnitude compared to
its ccc counterpart. The lethal effect of chromosomal
disruption in E. coli was investigated by site-specific in-
sertion of the lcc integrating pDNA vector using Int-attB
systems from bacteriophages λ and Φ80. Our results
linking site of chromosomal disruption to degree of le-
thality agree with previous work by Cui et al. (2007)
who reported that the closer the linearization of the
chromosome occurred to the E. coli origin of replica-
tion, the stronger was the observed growth defect [36].
Our microscopy results indicated a dramatic reduction
in cell size and surrounding cellular debris following
genome disruption, which we attribute to replication
inhibition and associated cellular stress, phenotypes we
are presently investigating further in bacterial and
mammalian cells. The generation of filamentous cells
similarly may be due to SOS-independent filamenta-
tion arising from inhibited or dramatically slowed rep-
lication [36].
Considering the lethal effect of lcc DNA vector inte-
gration into host chromosome, lcc based gene replace-
ment vectors will likely provide a safer option for
targeted recombination events. We report elsewhere that
lcc vector integration into human cells results in
chromosomal disruptions and cell death, preventing
propagation of the lcc vector-integrated cell and its nat-
ural elimination from the transfected cell population. As
such, mini lcc vectors potentially serve as ideal choice
for knock-in and gene replacement studies in stem and
other pluripotent cells for the generation of transgenic
plant and animal models and regenerative medicine,
avoiding damage and side effects of integration.Conclusion
Mini lcc DNA vector constructs were generated in vivo
exploiting the bacteriophage PY54-derived Tel-pal re-
combination system in a conditional recombinase ex-
pression scheme. The mini lcc DNA vectors provide a
safer alternative to conventional pDNA vectors without
compromising utility. In addition to a unique multi-
target sequence, each vector is equipped with two SV40
enhancer sequences at the two covalently closed ends of
the linear plasmids to facilitate the nuclear uptake and
enhance the transfection efficiency and expression of the
GOI. The production system reported here and its asso-
ciated safety profile may serve as a basis for simplified,
scalable, and safer DNA vector production that could
drive the design of virtually limitless innovations with
applications to health, agriculture, and industry.
Methods
Strains and plasmids
E. coli K-12 strains were used in the generation of all
recombinant cell constructs and DH5α and JM109, in
particular, were employed as hosts for plasmid con-
structions and amplification.
A list of bacterial and phage strains used in this study
are shown in Table 1.
Construction of Recombinant Cells (R-cells)
W3110 was used for chromosomal engineering studies
and in vivo recombinase expression as follows. Protelo-
merase coding gene tel was amplified from bacterio-
phage PY54 lysate using the following primers: Tel-F
50-GCGGATCCTGGGTTACTTTAATTTGTGTGTT-30
and Tel-R 50-CGCTCGAGTTACTCCATATTTTCAGT
CCATGCTTGT-30 (annealing Tm 64°C). Protelomerase
coding gene telN was amplified from bacteriophage
N15 lysate using primers: TelN-F 50-ATCGGATCCC
GATATCCAGAGACTTAGAAACGGG-30 and TelN-R
50- ATATAAAGCTTCTTTTAGCTGTAGTACGTTTCC
CATGCG-30 (annealing Tm 62°C). As a positive con-
trol for in vivo production of modified DNA vectors,
the recombinase encoding gene cre was amplified from
bacteriophage P1rev6 lysate using primers: Cre-F 50-
GGAATTCCGGTCGCTGGCGTTTCTATGAC-30 and
Cre-R 50-CGCTCGAGTGAATATTAGTGCTTACAGA
CAG-30 (annealing Tm 66°C). Italicized regions denote
restriction sites for BamHI, XhoI, HindIII, and EcoRI.
PCR amplifications were conducted using Phusion
Flash High-Fidelity PCR Master Mix (New England
Biolabs) for 30 s at 98°C for initial denaturation, 30
cycles of 5 s at 98°C, 10 s at annealing Tm, 45 s at
72°C, and 2 min at 72°C for final extension to generate
cre (1.3 kb), tel (2.1 kb), and telN (2.3 kb) fragments.
Constructs were tested and confirmed by colony PCR
and analytical digestion. PCR products were purified
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digested with the listed enzymes (New England Biolabs).
Recombinase genes were cloned into the MCS of the in-
ducible prokaryotic expression plasmid vector pPL451
(Accession #AB248919) to produce pNN1, pNN2, and
pNN3 vectors. pPL451 (4.2 kb) imparts temperature-
regulated expression of the cloned gene via CI[Ts]857-
mediated repression of the λ pL strong promoter. A list
of plasmids used or constructed in this study is shown
in Table 1. All primers were designed using the Gene
Runner 3.01 (Hastings Software, Inc) and synthesized
commercially (Sigma-Aldrich, Inc). R-cells were con-
structed via insertion of recombinase genes into E. coli
W3110 chromosome using the pBRINT-cat integrating
plasmids, which facilitate the homologous recombin-
ation and chromosomal integration of cloned sequence
of interest into the lacZ gene of E. coli [37]. For each
plasmid construct encoding inducible expression of a
cloned recombinase in pPL451, the cI857-PL-X-tL cas-
sette (where X = cre, tel or telN) was amplified from the
pNN1 to 3 constructs by the cI857X-F 50-TCCCCGCG
GAGCTATGACCATGATTACGAATTGC-30, cI857telN/
cre-R 50-GGACTAGTCCCCATTCAGGCTGCGCAAC
TGTTG-30, and cI857tel-R 50-GCTCTAGAGCAG
GCTGCGCAACTGTTGGGAAG-30 primers with SacII,
SpeI, and XbaI sites respectively. The amplified cassettes
were cloned into the MCS of pBRINT (CmR) integrating
plasmid to produce pNN4, pNN5, and pNN6 integrating
pDNA constructs. Amplification have been performed by
the Phusion Flash High-Fidelity PCR Master Mix (New
England Biolabs) for 10 s at 98°C for initial denaturation,
30 cycles of 1 s at 98°C, 5 s at 68°C, 120 s at 72°C, and 1
min at 72°C for final extension to generate cI857-cre (2.8
kb), cI857-tel (3.2 kb), and cI857-telN (3.5 kb) fragments.
Constructs were tested and confirmed by colony PCR and
analytical digestion.
E. coli cells were grown in Luria–Bertani (LB) medium
and plated on LB-Agar plates composed of 1.0% Tryp-
tone, 0.5% Yeast Extract, 1.0% NaCl, pH 7.0. Antibiotics
(Ab) (Sigma-Aldrich, Inc) were used at the following
concentrations for the growth of cells carrying multi-
copy plasmids: ampicillin (Ap, 100 μg/ml in H2O), chlor-
amphenicol (Cm, 25 μg/ml in isopropanol), gentamycin
(Gm, 15 μg/ml in H2O), and kanamycin (Km, 50 μg/ml
in H2O). H2O used for dilution of primers, plasmids,
antibiotics, and production of competent cells is
nuclease-free sterile molecular grade water (Sigma-
Aldrich, Inc). To achieve chromosomal integration of
the pNN4 to 6 constructs into Rec+ W3110, a 1:100 di-
lution of fresh overnight cells was grown on SOB media
(2.0% Tryptone, 0.5% Yeast Extract, 2.0% NaCl, 1.0% KCl,
1.0% MgCl2 , and 1.0% MgSO4) at 37°C to A600 = 0.4 - 0.6
and cells were harvested by centrifugation at 5K RPM for
5 min. Cells were washed in water three times and W3110cells were transformed by 1 μg of pNN4, 5, or 6 integrat-
ing vectors via electroporation at 800 v. Cells were recov-
ered in SOC (SOB with 2.0% Glucose) at 30°C for 1 h,
then spread onto selective media on 12.5 μg/ml of chlor-
amphenicol, 100 μg/ml of 5-bromo-4-chloro-indolyl-β-D-
galactopyranoside (X-Gal) (Promega), and 0.1 mM of
Isopropyl β-D-1-thiogalactopyranoside (IPTG) (Sigma-
Aldrich, Inc) added to LB agar plates and incubated
overnight at 30°C. To make a 50 mg/ml stock solution,
500 mg X-Gal were dissolved in 10 ml dimethylforma-
mide. Protect plates from light. White colonies were
selected and further screened for sensitivity to ampicillin
and chloramphenicol. White ApS colonies indicated loss
the pNN integrating plasmids after disruptive insertion
of the cI857-PL-X-tL cassette into the lacZ gene, gener-
ating recombinant derivatives, W1NN, W2NN, and
W3NN (Table 1). W3110 [lacZ::cat- cI857(cre/tel/telN)]
recombinants were confirmed for presence of the cI857-
PL-X-tL cassette and temperature-regulated, conditional
expression of recombinanse, by colony PCR using Taq
polymerase enzyme (NEB), sequencing (Sigma), and
SDS PAGE (BioRad) at various temperatures between
30°C and 42°C. For the selection of cells carrying the
antibiotic selection markers integrated in the chromo-
some, the following concentrations were used: Cm (12.5
μg/ml), Gm (5 μg/ml), and Km (20 μg/ml).
Construction of modified/ new generation of pDNA
Vectors
The multi-purpose target site, named Super Sequence
(SS), was designed to carry Cre, Flp and TelN minimal
targets sites (loxP-FRT-telRL) respectively, all within the
Tel 142 bp target site, pal. SS also carries a 78 bp SV40
enhancer sequence that flanks each side of the pal se-
quence to facilitate nuclear translocation and enhancing
transfection efficiency. The SS fragment was synthesized
by the GeneScript and cloned into the pUC57 by EcoRI
and HindIII. Commercial eukaryotic expression plasmid
vector, pGL2-promoter (5.8 kb) (Promega), was modified
by replacement of the luc gene (1.65 kb) with egfp
(790 bp) from pGFP (Clontech, Inc.) to form pNN7
(Genescript, Inc.) (4.9 kb) Next, SS was cloned imme-
diately upstream of the SV40 promoter + intron site
of pNN7 to form pNN8 (5.3 kb). Then the SS frag-
ment was cloned downstream of the poly A site of
pNN8 to form pNN9 (5.6 kb). The multi-copy pDNA
vector pNN9 carries 2 SS sites that flank the egfp gene
cassette and can be converted to a “minicircle” DNA
vector (mediated by Cre-loxP; Flp-FRT), or a mini linear
covalently closed DNA vector (mediated by TelN-telRL;
Tel-pal). R-cells were transformed by 1 μg of pNN7 to
9 DNA constructs on LB + Ap (50 μg/ml) to A600 =
0.6 at 30°C with aeration. To induce recombinase
expression and plasmid conformational conversion,
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recombinase expression at 42°C for 30 min at mid-
logarithmic phase of bacterial growth, before being
transferred to 30°C overnight. Cells were then harvested
and plasmid extracted (Omega kit, VWR). Plasmid top-
ology was assayed by agarose gel electrophoresis and
digestion. Standard recombinant DNA techniques were
performed as described by Sambrook et al. (1989).
Chromosomal Integration Assays of Linear Covalently
Closed (LCC) DNA
“CRIM (conditional-replication, integration, and modu-
lar)” integrating plasmids [25] that possess a R6K origin
of replication and a phage attachment (attP) site were
modified to carry the SS fragment. SS was cloned into
the pAH120 and pAH153 constructs (from NBRP;
Table 1) by ClaI and BamHI (New England Biolabs) to
generate the pNN10 (3.3 kb) and pNN11 (2.6 kb) con-
structs, respectively. Plasmids were integrated into the
host bacterial attachment (attB) site by supplying phage
integrase (Int) from the helper plasmids. Plasmid pNN10
and pNN11 constructs were amplified in DH5α(λpir) or
BW23474, and the successful clones were confirmed by
restriction pattern digestion and colony PCR. Int helper
plasmids pINT-ts (λ int) and pAH123 (Φ80 int) that ex-
press int from λ pL under CI[Ts]857 control and carry a
temperature sensitive pSC101 ori were used for integra-
tion of CRIM, pNN10 and pNN11 plasmids into their
corresponding chromosomal attB sites of pir— hosts that
are non-permissive for plasmid replication.
R-Cells W1NN, W2NN, and W3NN (Table 1) W3110
[lacZ::cat- cI857(cre/tel/telN)] were grown in 2 ml of
SOB cultures at 30°C to an optical density of A600 = 0.6
and then electroporated and transformed by 50 ng
helper plasmids pINT-Ts (λ int) or pAH123 (Φ80 int)
and selected on LB + ampicillin agar at 30°C. R-Cells
carrying helper plasmids were grown in 50 ml of SOB +
ampicillin at 30°C to A600 = 0.6 then transformed by 1
μg of pAH120, pNN10 (pAH120+SS), pAH153, pNN11
(pAH153+SS) DNA, suspended in SOC at 37°C for 1 h
for recovery and Int expression and at 42°C for 30 min
for lose of helper plasmid, then selected on LB + anti-
biotic (15 μg/ml Km for pAH120, pNN10 and 5 μg/ml
Gm for pAH153, pNN11) and incubated overnight at
37°C. Positive bacterial growth on selective media (15
μg/ml Km, or 5 μg/ml Gm) and negative bacterial
growth on ampicillin media represents stable integration
of the gene of interest and loss of the helper Int expres-
sion plasmid. Single-copy integrants W4NN to W15NN
represent the SS+ pAH120 (pNN10), SS- pAH120, SS+
pAH153 (pNN11), and SS- pAH153 pDNA integrated
into the W3110 or W3110 [lacZ::cat-cI857(cre/tel/telN)])
were screened and selected by PCR using predesigned
primers [25].Viability Assays of Linear Covalently Closed (LCC) DNA
integration
Single copy pAH120, pNN10 (pAH120+SS), pAH153,
pNN11 (pAH153+SS) DNA integrants W4NN to
W15NN were isolated on selective media.
Integrants were grown in 2 ml LB media + selective
antibiotic at 30°C to an optical density of A600 = 0.4 and
then divided into two groups of 1 ml each and grown to
A600 = 1. The first group was grown at 30°C with
repressed cre/tel/telN expression and the second group
was grown at 42°C, induced for cre/tel/telN expression.
Cells were spread on selective plated and grew overnight
at 30°C and 42°C, respectively. Viability was assayed by
colony counting and size of the colonies grew at 30°C
versus 42°C.
Visualization of cells
Cells were visualized by gram staining as previously
described [38]. Briefly, integrated cells were grown in 2
ml of LB media + selective antibiotic from freshly grown
cells at 30°C to early log phase A600 = 0.2 and then were
divided in two tubes and grown at 30°C and 42°C to late
log phase, A600 = 0.8. Bacterial smears were then pre-
pared on the slide and heat fixed and gram stained. Pic-
tures of bacteria were taken at 1000X magnification.
From pictures, 400 random cells were chosen for meas-
urement under all tested conditions.
Abbreviations
Bp: Base pair(s); CCC: Circular covalently closed; DTS: DNA nuclear targeting
sequence; GOI: Gene of interest; IF: Integration frequency; kb: Kilo-base(s);
kDa: KiloDalton(s); LB: Luria-Bertani medium; LCC: Linear covalently closed;
MCS: Multiple cloning site(s); MIDGE: Minimalistic immunogenic defined
gene expression; NLS: Nuclear localization signal; NPC: Nuclear membrane
pore complex; o: Operator; PAGE: Polyacrylamide gel electrophoresis;
pDNA: Plasmid DNA; p: Promoter; protelomerase: Prokaryotic telomerase;
R: Recombinant cells; SDS: Sodium dodecyl sulfate; SS: Super Sequence;
[ ]: Denotes plasmid-carrier state.
Competing interests
The authors declare that there is no conflict of interests in the submission of
this manuscript.
Authors’ contributions
NN conducted the experimental work and significantly toward the design
and writing of this manuscript. RAS designed the system described here and
contributed significantly to the direction of the project and writing of the
manuscript. Both authors read and approved the final manuscript.
Authors’ information
RAS is currently an Assistant Professor of Pharmaceutical Science at
University of Waterloo, School of Pharmacy and SDM Professor of Business
and Entrepreneurship. NN is currently a PhD candidate at University of
Waterloo.
Acknowledgements
This work was supported by UW Start-up funds to RAS; and Drug Safety and
Effectiveness Cross-Disciplinary Training (DSECT) Scholarship provided by
Canadian Institute of Health Research (CIHR), Ontario Graduate Scholarship
(OGS), and Waterloo Institute of Nanotechnology (WIN) fellowship to NN.
The authors also want to thank Gary Tran for his assistance in generating the
pNN1 construct.
Received: 2 October 2012 Accepted: 25 November 2012
Published: 6 December 2012
Nafissi and Slavcev Microbial Cell Factories 2012, 11:154 Page 13 of 13
http://www.microbialcellfactories.com/content/11/1/154References
1. Branca MA: Gene therapy: cursed or inching towards credibility? Nat
Biotechnol 2005, 23:519–521.
2. Miller AM, Dean DA: Tissue-specific and transcription factor-mediated
nuclear entry of DNA. Adv Drug Deliv Rev 2009, 61:603–613.
3. Vidal M, Hoekstra D: In vitro fusion of reticulocyte endocytic vesicles with
liposomes. J Biol Chem 1995, 270:17823–17829.
4. Vaysse L, Gregory LG, Harbottle RP, Perouzel E, Tolmachov O, Coutelle C:
Nuclear-targeted minicircle to enhance gene transfer with non-viral
vectors in vitro and in vivo. J Gene Med 2006, 8:754–763.
5. Chahine MN, Pierce GN: Therapeutic targeting of nuclear protein import
in pathological cell conditions. Pharmacol Rev 2009, 61:358–372.
6. Zanta MA, Belguise-Valladier P, Behr J-P: Gene delivery: A single nuclear
localization signal peptide is sufficient to carry DNA to the cell nucleus.
Proc Natl Acad Sci 1999, 96:91–96.
7. Tanimoto M, Kamiya H, Minakawa N, Matsuda A, Harashima H: No
enhancement of nuclear entry by direct conjugation of a nuclear
localization signal peptide to linearized DNA. Bioconjug Chem 2003,
14:1197–1202.
8. Spies B, Hochrein H, Vabulas M, Huster K, Busch DH, Schmitz F, Heit A,
Wagner H: Vaccination with plasmid DNA activates dendritic cells via
Toll-Like Receptor 9 (TLR9) but functions in TLR9-deficient mice.
J Immunol 2003, 171:5908–5912.
9. Darquet A-M Rangara R, Kreiss P, Schwartz B, Naimi S, Delaère P, Crouzet J,
Scherman D: Minicircle: an improved DNA molecule for in vitro and
in vivo gene transfer. Nature 1999, 6:209–218.
10. Mayrhofer P, Schleef M, Jechlinger W: Use of minicircle plasmids for gene
therapy. In Gene Therapy of Cancer. Edited by Walther W, Stein U.: Human
Press; 2009:87–104 [Springer Protocols: Methods in Molecular Biology.
Volume 542].
11. Faurez F, Dory D, Le Moigne V, Gravier R, Jestin A: Biosafety of DNA
vaccines: New generation of DNA vectors and current knowledge on the
fate of plasmids after injection. Vaccine 2010, 28:3888–3895.
12. Prazeres DMF: Plasmid Biopharmaceuticals: basics, application, and
manufacturing. New Jersey: Wiley; 2011.
13. Rodríguez EG: Nonviral DNA vectors for immunization and therapy:
design and methods for their obtention. J Mol Med 2004, 82:500–509.
14. López-Fuertes L, Pérez-Jiménez E, Vila-Coro AJ, Sack F, Moreno S, Konig SA,
Junghans C, Wittig B, Timon M, Esteban M: DNA vaccination with linear
minimalistic (MIDGE) vectors confers protection against Leishmania
major infection in mice. Vaccine 2002, 21:247–257.
15. Schakowski FGM, Junghans C, Schroff M, Buttgereit P, Ziske C, Schöttker B,
König-Merediz SA, Sauerbruch T, Wittig B, Schmidt-Wolf IG: A novel
minimal-size vector (MIDGE) improves transgene expression in colon
carcinoma cells and avoids transfection of undesired DNA. Mol Ther 2001,
5:3793–3800.
16. Schakowski F, Gorschluter M, Buttgereit P, Märten A, Lilienfeld-Toal MV,
Junghans C, Schroff M, König-Merediz SA, Ziske C, Strehl J, Sauerbruch T,
Wittig B, Schmidt-Wolf IG: Minimal size MIDGE vectors improve transgene
expression in vivo. In Vivo 2007, 21:17–23.
17. Valentin N, Rybchin ANS: The plasmid prophage N15: a linear DNA with
covalently closed ends. Mol Microbiol 1999, 33:895–903.
18. Deneke J, Ziegelin GN, Lurz R, Lanka E: The protelomerase of temperate
Escherichia coli phage N15 has cleaving-joining activity. Proc Natl Acad Sci
U S A 2000, 97:7721–7726.
19. Grigoriev PS, Lobocka M: Determinants of segregational stability of the
linear plasmid-prophage N15 of Escherichia coli. Mol Microbiol 2001,
42:355–368.
20. Heinrich J, Schultz J, Bosse M, Ziegelin G, Lanka E, Moelling K: Linear closed
mini DNA generated by the prokaryotic cleaving-joining enzyme TelN is
functional in mammalian cells. J Mol Med 2002, 80:648–654.
21. Stefan H, Iris K, Rudi L, Erich L, Bernd A: PY54, a linear plasmid prophage
of Yersinia enterocolitica with covalently closed ends. Mol Microbiol 2003,
48:989–1003.
22. Chen Q, Narayanan K: Crude protein extraction protocol for phage
N15 protelomerase in vitro enzymatic assays. Anal Biochem 2011,
414:169–171.
23. Sauer B, Henderson N: Site-specific DNA recombination in mammalian
cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci
1988, 85:5166–5170.24. Wang Y, Krushel LA, Edelman GM: Targeted DNA recombination in vivo
using an adenovirus carrying the cre recombinase gene. Proc Natl Acad
Sci 1996, 93:3932–3936.
25. Haldimann A, Wanner BL: Conditional-replication, integration, excision,
and retrieval plasmid-host systems for gene structure-function studies of
bacteria. J Bacteriol 2001, 183:6384–6393.
26. Dürrschmid K, Reischer H, Schmidt-Heck W, Hrebicek T, Guthke R, Rizzi A,
Bayer K: Monitoring of transcriptome and proteome profiles to
investigate the cellular response of E. coli towards recombinant protein
expression under defined chemostat conditions. J Biotechnol 2008,
135:34–44.
27. Shatzman AR, Gross MS, Rosenberg M: Expression using vectors with
phage λ regulatory sequences. Curr Protoc Mol Biol 2001, Chapter 16:Unit
16.3.
28. Srivastava IK, Singh M: DNA vaccines: Focus on increasing potency and
efficacy. Int J Pharm Med 2005, 19:15–28.
29. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY,
Robbins RC, Kay MA, Longaker MT, Wu JC: A nonviral minicircle vector for
deriving human iPS cells. Nat Methods 2010, 7:197–199.
30. Luke JM, Vincent JM, Du SX, Gerdemann U, Leen AM, Whalen RG,
Hodgson CP, Williams JA: Improved antibiotic-free plasmid vector design
by incorporation of transient expression enhancers. Gene Ther 2011,
18:334–343.
31. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs
present in bacteria DNA rapidly induce lymphocytes to secrete
interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci
1996, 93:2879–2883.
32. Catanese DJ Jr, Fogg JM, Schrock DE II, Gilbert BE, Zechiedrich L:
Supercoiled minivector DNA resists shear forces associated with gene
therapy delivery. Gene Ther 2012, 19:94–100.
33. Chen Z-Y, He C-Y, Ehrhardt A, Kay MA: Minicircle DNA vectors devoid of
bacterial DNA result in persistent and high-level transgene expression
in vivo. Mol Ther 2003, 8:495–500.
34. Baum C, von Kalle C, Staal FJT, Li Z, Fehse B, Schmidt M, Weerkamp F, Karlsson S,
Wagemaker G, Williams DA: Chance or necessity? Insertional mutagenesis in
gene therapy and its consequences. Mol Ther 2004, 9:5–13.
35. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N,
McIntyre E, Radford I, Villeval J-L, Fraser CC, Cavazzana-Calvo M, Fischer A: A
serious adverse event after successful gene therapy for X-linked severe
combined immunodeficiency. N Eng J Med 2003, 348:255–256.
36. Cui T, Moro-oka N, Ohsumi K, Kodama K, Ohshima T, Ogasawara N, Mori H,
Wanner B, Niki H, Horiuchi T: Escherichia coli with a linear genome.
EMBO Rep 2007, 8:181–187.
37. Le Borgne S, Palmeros BÌ, Valle F, Bolivar F, Gosset G: pBRINT-Ts:
a plasmid family with a temperature-sensitive replicon, designed for
chromosomal integration into the lacZ gene of Escherichia coli.
Gene 1998, 223:213–219.
38. Cappuccino JG, Natalie S: Microbiology: A laboratory manual: Benjamin-
Cummings Publishing Company; 2013. ISBN -13: 978–0321840226.
39. Andreas S, Schwenk F, Küter-Luks B, Faust N, Kuhn R: Enhanced efficiency
through nuclear localization signal fusion on phage PhiC31-integrase:
activity comparison with Cre and FLPe recombinase in mammalian cells.
Nucleic Acids Res 2002, 30:2299–2306.
40. Kvitko B, Bruckbauer S, Prucha J, McMillan I, Breland E, Lehman S, Mladinich
K, Choi K-H, Karkhoff-Schweizer R, Schweizer H: A simple method for
construction of pir+ Enterobacterial hosts for maintenance of R6K
replicon plasmids. BMC Res Notes 2012, 5:157.
41. Bachmann BJ: Pedigrees of some mutant strains of Escherichia coli K-12.
Bacteriol Rev 1972, 36:525–557.
42. Kaur T, Al Abdallah Q, Nafissi N, Wettig S, Funnell BE, Slavcev RA:
ParAB-mediated intermolecular association of plasmid P1 parS Sites.
Virology 2011, 421:192–201.
43. Love CA, Lilley PE, Dixon NE: Stable high-copy-number bacteriophage λ
promoter vectors for overproduction of proteins in Escherichia coli.
Gene 1996, 176:49–53.
doi:10.1186/1475-2859-11-154
Cite this article as: Nafissi and Slavcev: Construction and
Characterization of an in-vivo Linear Covalently Closed DNA Vector
Production System. Microbial Cell Factories 2012 11:154.
